Protocol Design Trends Investigators Should Look for When Selecting Studies
For investigative sites, selecting studies for increased patient centricity, whether through decentralized trials, patient input in study design, or remote…
Building a Global Research Network: Chronic Kidney Disease as a Public Health Crisis
At least 20% of people aged 65 to 74, and 50% of people over 75, have chronic kidney disease. However,…
Missed Revenue in Clinical Research: 1 Study, 10 Sites, $154,000 Caught
Whether from faulty sponsor payment systems, incomplete invoicing, or other causes, private practice investigational sites routinely miss out on significant…
Start with the Patient in Mind – Interview With Patient Partner Donnie King
Start with the patient in mind — let’s renew our resolve to represent those who participate in studies to advance…
Overcoming Barriers to Enrolling Renal Patients in Clinical Trials: Q&A With Kurt Mussina
Kurt Mussina, General Manager of Frenova Renal Research and Vice President of Clinical Studies Operations for Fresenius Medical Care North…
Market Research in the Age of AI and Big Data
In a competitive and global business environment, pharmaceutical companies are starting to become wiser when it comes to using market…
Changing Ways: Patient Participation
For many patients across a wide range of therapeutic areas, participation in a clinical trial can provide access to important…
Prevent the Real World From Derailing Your Clinical Trial: Focus On Protocol Design
Clinical trial sponsors are continually seeking ways to improve the speed and efficiency of their clinical development projects. However, they…
Vifor Case Study: A Pivotol Phase III Study for FDA Approval of Velphoro® (Sucroferric Oxyhydroxide), a Hyperphosphatemia Medication
Enrolling patients affected by chronic kidney disease can be particularly challenging. With multiple comorbidities, they are often reluctant to undergo…
Starting With The Patient In Mind
In our desire for efficiency, it’s easy to forget that the patient care we provide during a clinical trial isn’t…